Empatica’s Aura System Receives European CE Mark for Detecting Early Symptoms of COVID-19 Using Wearables

 Empatica’s Aura System Receives European CE Mark for Detecting Early Symptoms of COVID-19 Using Wearables

Empatica’s Aura System Receives European CE Mark for Detecting Early Symptoms of COVID-19 Using Wearables

Shots:

  • Empatica received its CE mark for Aura system as a class lla medical device, along with its remote health monitoring platform (Care) meet safety and performance requirements in the EU
  • Aura system detects and alerts to respiratory infections including COVID-19, before the visible appearance of symptoms. The system has demonstrated a sensitivity of 0.94 in identifying patients with a possible infection in validation studies
  • Aura system collects data from the wearer, including their heart rate, pulse variability and the electrical activity of their skin, to spot the small changes that occur in the body

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: BioWorld

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post